What is the recommended dosage and treatment duration of Macrobid (nitrofurantoin monohydrate) for uncomplicated urinary tract infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Macrobid Dosing for Uncomplicated UTI

For uncomplicated urinary tract infections in women, prescribe nitrofurantoin monohydrate/macrocrystals (Macrobid) 100 mg twice daily for 5 days. 1

Standard Dosing for Women

  • The IDSA and European Society for Microbiology and Infectious Diseases recommend 100 mg twice daily for 5 days as the optimal first-line regimen for uncomplicated cystitis in women. 1

  • This 5-day course achieves clinical cure rates of 88-93% and bacterial cure rates of 81-92%, which is equivalent to trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days. 1

  • The European Association of Urology also endorses nitrofurantoin as first-line therapy at 100 mg twice daily for 5 days. 1

Alternative Dosing Formulations

  • Nitrofurantoin macrocrystals can be dosed at 50-100 mg four times daily for 5 days if the twice-daily formulation is unavailable. 1

  • For VRE (vancomycin-resistant Enterococci) UTIs specifically, increase to 100 mg four times daily. 1

Dosing for Men

For males with uncomplicated UTI, prescribe nitrofurantoin 100 mg every 6 hours (four times daily) for 7-14 days, with 14 days recommended when prostatitis cannot be excluded. 2

Critical Caveat for Males

  • Nitrofurantoin has substantially lower efficacy in males, with a 25% failure rate compared to 10-16% in females. 2

  • Consider alternative agents (trimethoprim-sulfamethoxazole 160/800 mg twice daily for 14 days or fluoroquinolones for 5-7 days) as first-line options in males due to this higher failure rate. 2

Absolute Contraindications

  • Do not prescribe nitrofurantoin if creatinine clearance is <60 mL/min due to inadequate urinary drug concentrations and increased risk of peripheral neuropathy. 2

  • Avoid if early pyelonephritis is suspected, as nitrofurantoin does not achieve adequate tissue concentrations for upper tract infections. 1

  • Contraindicated in the last trimester of pregnancy (last 3 months). 3

Pediatric Dosing

  • For children ≥12 years: 100 mg twice daily for 7 days. 1

  • For children <12 years: 5-7 mg/kg/day divided into 4 doses (maximum 100 mg/dose) for 7 days or at least 3 days after obtaining sterile urine. 1

Common Pitfalls to Avoid

  • Do not extend treatment beyond 7 days in women unless symptoms persist, as shorter courses minimize adverse effects (nausea, headache) while maintaining efficacy. 1

  • Do not order routine post-treatment urinalysis or urine cultures for asymptomatic patients. 1

  • For women whose symptoms do not resolve by end of treatment or recur within 2 weeks, obtain urine culture with susceptibility testing and consider retreatment with a 7-day regimen using another agent. 1

When to Choose Alternatives

  • If local E. coli resistance to trimethoprim-sulfamethoxazole is <20%, consider TMP-SMX 160/800 mg twice daily for 3 days as an alternative first-line option. 1

  • Fosfomycin trometamol 3 g single dose is an alternative with slightly lower efficacy than nitrofurantoin. 1

  • Reserve fluoroquinolones for more invasive infections due to resistance concerns and collateral damage to normal flora. 1

References

Guideline

Nitrofurantoin Dosing for Uncomplicated UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Nitrofurantoin Dosing for Male UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Nitrofurantoin--clinical relevance in uncomplicated urinary tract infections].

Medizinische Monatsschrift fur Pharmazeuten, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.